Gemina Laboratories Ltd.
GLAB
Classement en actions
#35641
Gemina Laboratories Ltd. is a Canadian biotechnology company dedicated to the... Gemina Laboratories Ltd. is a Canadian biotechnology company dedicated to the research, development, and commercialization of in-vitro diagnostics. The firm invents innovative surface functionalization chemistries for identifying pathogens and biomarkers. Among its current projects, Gemina is advancing the POC Antigen COVID test, a rapid, point-of-care lateral flow assay strip specifically designed to detect active COVID-19 infections. The company maintains its headquarters in Vancouver, Canada.
Prix de l'action
$0.04377166
Dernière synchronisation: 2026-02-05
Capitalisation boursière
$3.35M
Changement (1 jour)
-0.30%
Changement (1 an)
-81.04%
Pays
CA
Échange Gemina Laboratories Ltd. (GLAB)
Catégorie
Healthcare
Historique du prix de l'action pour Gemina Laboratories Ltd. (GLAB)
Prix de clôture le plus élevé : $0.05 le 2026-10-01
Prix de clôture le plus bas : $0.42 le 2022-03-01
Prix de clôture le plus bas : $0.42 le 2022-03-01
Historique du prix de l'action de Gemina Laboratories Ltd. de 2022 à 2026
Performance annuelle du prix de l'action
| Année | Performance |
|---|---|
| 2026 (TTM) | -17.43% |
| 2025 | -80.23% |
| 2024 | 53.58% |
| 2023 | 50.57% |
| 2022 | 0.00% |
Prix de l'action pour des entreprises similaires ou concurrentes
| Entreprise | Prix de l'action | Variation 1a% | Pays |
|---|---|---|---|
| $527.18 | 23.62% |
US
|
|
| $251.29 | 835.90% |
US
|
|
| $137.83 | -3.78% |
AU
|
|
| $890.85 | 9.42% |
NL
|
|
| $752.87 | 7.01% |
CH
|
